Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01555619 · ClinicalTrials.gov registry record
Quadripolar Pacing Post Approval Study
A clinical trial of Heart Failure, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 1,971
- Enrollment target
- 20
- Study locations
NCT01555619: Completed study of Heart Failure, sponsored by Abbott Medical Devices.
NCT01555619 is a study of Heart Failure that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,971 participants, roughly in line with the 2,044-participant average among 397 other Heart Failure trials with a reported enrollment target. The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01555619, a study of Heart Failure, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 1,971 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this post-approval study is to evaluate the acute and chronic performance of a Quadripolar CRT-D device system in a patient population indicated for cardiac resynchronization therapy (CRT).
Primary Outcome
Complication free survival rate through 5 years for complications related to the CRT-D system
Conditions Studied
Interventions
- DEVICE CRT-D System
Study Locations (20)
California
- Comprehensive Cardiovascular - Bakersfield
- Scripps Green Hospital - La Jolla
- USC Unversity Hospital - Los Angeles
- Fogarty Institute - Mountain View
- Premier Cardiology, Inc. - Newport Beach
- Cardiac Rhythm Specialists, Inc. - Northridge
- St. Joseph Heritage Medical Group - Orange
- Regional Cardiology Associates - Sacramento
- St. Joseph's Medical Center - Stockton
- Cardiology Associates Medical Group, Inc. - Ventura
Florida
- Florida Electrophysiology Associates - Atlantis
- Yoel R. Vivas, MD - Boynton Beach
- Jorge Diaz - Lake Mary
- Naples Heart Rhythm Specialists - Naples
Alabama
- Cardiology, P.C. - Birmingham
- Heart Center Research, LLC/Research Center - Huntsville
- Southeastern Cardiology Consultants PC - Montgomery
Arkansas
- Washington Regional Medical Center - Fayetteville
- Arkansas Heart Hospital - Little Rock
Arizona
- Arizona Arrhythmia Research Center - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,971 participants |
| Start Date | 2012-02-15 |
| Est. Completion | 2019-02-28 |
What the finished NCT01555619 record still lists
NCT01555619 is an observational study that tracks outcomes without assigning an intervention. Its 1,971 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 2,044-participant average among 397 other Heart Failure trials with a reported enrollment target.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which CRT-D System is the first listed.
NCT01555619 names 20 study sites across 5 states, led by California, Florida, Alabama.
Frequently Asked Questions
What is clinical trial NCT01555619 about?
NCT01555619 is a clinical study titled "Quadripolar Pacing Post Approval Study". The purpose of this post-approval study is to evaluate the acute and chronic performance of a Quadripolar CRT-D device system in a patient population indicated for cardiac resynchronization therapy (CRT).
What is the current status of trial NCT01555619?
This trial is currently completed. The enrollment target is 1,971 participants. The study started on 2012-02-15. Estimated completion is 2019-02-28.
What conditions does trial NCT01555619 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT01555619?
The interventions under investigation include: CRT-D System (DEVICE).
Who is sponsoring clinical trial NCT01555619?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01555619 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01555619's enrollment target sits among peer trials
1,971 46th of 397 higher than 352 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06062394 · 1,980 participants · NA
Penn Medicine Healthy Heart
- NCT07321886 · 1,980 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- NCT04251052 · 1,956 participants · NA
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI